Promotion of Medications for Opioid Use Disorder Aimed at Urban, Not Rural, Prescribers
Researchers looked at data for 18,318 physicians who received opioid use disorder medication promotions, totaling $9.6 million during the study period.
Opioid-Use Disorder
Total Opioid Overdose Deaths Down With Medicaid Expansion
Medicaid expansion is associated with a reduction in total opioid overdose deaths and with increases in methadone-related mortality.
Teens Who Misuse Opioids Likely to Engage in Other Risky Behaviors
Adolescents who report misusing prescription opioids are more likely to have engaged in a range of other risky behaviors.
Benzodiazepine, Opioid Agonist Coprescription May Raise Mortality Risk
Coprescription of benzodiazepines and opioid agonist treatment (OAT) is associated with an increased risk for drug-related poisoning (DRP) mortality in opioid-dependent individuals.
Nearly 25 Percent of Adolescents, Young Adults Use Prescription Opioids
Prescription opioid use among teens and young adults is higher than expected, with most obtaining the drugs from friends and family.
Addressing Two Public Health Epidemics: Suicide and Opioid Addiction
Traditionally, suicide and overdose prevention in opioid use disorder involve stratifying risk based on certain demographic and clinical factors.
Mind-Body Therapy May Be Effective for Opioid-Treated Pain
Mind-body therapies were linked with small declines in opioid dose, a promising finding in light of concerns surrounding the scale of opioid prescriptions in the United States.
Time Spent in United States Linked to Opioid Use Among Immigrants
The adjusted rate of opioid use increased nearly 4-fold (adjusted odds ratio, 4.18; 95% CI, 1.76-9.96), from 4.7% among new immigrants to 14.8% among those who had been in this country for 15 years or more.
Exacerbated Opioid Overdose Death Rates Among All Racial, Age Groups
From 2015 to 2017, number of opioid-involved overdose deaths increased for nearly all racial/ethnic groups.
A New Center at Johns Hopkins Builds the Case for Psychedelic Research
A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.
Next post in General Psychiatry
